WallStreetZenWallStreetZen

NASDAQ: SLS
Sellas Life Sciences Group Inc Stock Ownership - Who owns Sellas Life Sciences Group?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Sellas Life Sciences Group Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
John Thomas BurnsCFO2023-12-062,929$1.08
$3.16kSell
Robert FrancomanoChief Commercial Officer2023-12-061,082$1.08
$1.17kSell
Angelos M. StergiouPresident and CEO2023-12-0612,268$1.08
$13.25kSell
Barbara A. WoodEVP Gen. Counsel Corp. Sec.2023-12-064,119$1.08
$4.45kSell

1 of 1

SLS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when SLS insiders and whales buy or sell their stock.

SLS Shareholders

What type of owners hold Sellas Life Sciences Group Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Hudson Bay Capital Management LP7.82%4,400,000$6.42MInsider
Vanguard Group Inc2.04%1,147,324$1.68MInstitution
Robert Eugene Kennedy2.01%1,130,300$1.65MInsider
Armistice Capital LLC1.46%820,000$1.20MInstitution
Mark W. Schwartz0.78%439,978$642.37kInsider
Angelos M. Stergiou0.67%376,421$549.57kInsider
Blackrock Inc0.50%279,804$408.51kInstitution
Geode Capital Management LLC0.44%245,603$358.58kInstitution
Group One Trading LP0.33%186,355$272.08kInstitution
Equitable Holdings Inc0.29%165,000$240.90kInstitution

1 of 3

SLS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
SLS6.21%13.47%Net Selling
ATRA54.24%11.13%Net BuyingNet Selling
MIST33.44%24.16%
BYSI14.02%0.00%
VTVT0.11%99.89%Net BuyingNet Buying
View Top Biotech Stocks

Sellas Life Sciences Group Stock Ownership FAQ

Who owns Sellas Life Sciences Group?

Sellas Life Sciences Group (NASDAQ: SLS) is owned by 6.21% institutional shareholders, 13.47% Sellas Life Sciences Group insiders, and 80.32% retail investors. Hudson Bay Capital Management LP is the largest individual Sellas Life Sciences Group shareholder, owning 4.40M shares representing 7.82% of the company. Hudson Bay Capital Management LP's Sellas Life Sciences Group shares are currently valued at $6.42M.

If you're new to stock investing, here's how to buy Sellas Life Sciences Group stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.